Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness

Cited by (1,629)

Items 401–500 of 1,629

1. Novel H1N1 Influenza A Viral Infection Complicated by Alveolar Hemorrhage
   Christopher R. Gilbert, Kumar Vipul, Michael Baram · 2010 · Respiratory Care
2. Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy
   Jessica S Little, Megha Tandon, Joseph Hong, Omar Nadeem, Adam Samuel Sperling, Noopur S Raje, Nikhil C. Munshi, Matthew J. Frigault, Sara Barmettler, Sarah Page Hammond · 2023 · Blood Advances
3. Real-time PCR assays for the detection and quantification of Streptococcus pneumoniae
   Hee Kuk Park, Hee Jung Lee, Wonyong Kim · 2010 · FEMS Microbiology Letters
4. Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*
   Carl O. Eriksson, Dionne A. Graham, Timothy M. Uyeki, Adrienne G. Randolph · 2012 · Pediatric Critical Care Medicine
5. Highly specific and rapid glycan based amperometric detection of influenza viruses
   Xikai Cui, Amrita Das, Abasaheb N. Dhawane, Joyce A. Sweeney, Xiaohu Zhang, Vasanta Chivukula, Suri S. Iyer · 2017 · Chemical Science
6. Prevention of influenza virus induced bacterial superinfection by standardized Echinacea purpurea , via regulation of surface receptor expression in human bronchial epithelial cells
   Selvarani Vimalanathan, R Schoop, Andy Suter, James B. Hudson · 2017 · Virus Research
7. Viral Sepsis in Children
   Neha Gupta, Robert P. Richter, Stephen Robert, Michele Y. F. Kong · 2018 · Frontiers in Pediatrics
8. Influenza-Induced Oxidative Stress Sensitizes Lung Cells to Bacterial Toxin-Mediated Necroptosis
   Norberto González-Juarbe, Ashleigh Nichole Riegler, Alexander S. Jureka, Ryan Paul Gilley, Jeffrey D. Brand, John E. Trombley, Ninecia R. Scott, Maryann P. Platt, Peter H. Dube, Chad M. Petit et al. · 2020 · Cell Reports
9. Do specific virus–bacteria pairings drive clinical outcomes of pneumonia?
   Jonathan A. McCullers · 2012 · Clinical Microbiology and Infection
10. Outside the Box and Into Thick Air: Implementation of an Exterior Mobile Pediatric Emergency Response Team for North American H1N1 (Swine) Influenza Virus in Houston, Texas
    Andrea Tania Cruz, Binita Patel, Michael C. DiStefano · 2009 · Annals of Emergency Medicine
11. Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice
    Kash, John C., Xiao, Yongli, Davis, A.Sally, Walters, Kathie-Anne, Chertow, Daniel S., Easterbrook, Judith D., Dunfee, Rebecca L., Sandouk, Aline, Jagger, Brett W., Schwartzman, Louis M. et al. · 2014 · Free Radical Biology and Medicine
12. The prevalence of influenza bacterial co-infection and its role in disease severity: A systematic review and meta-analysis
    Mengling Qiao, Gary Moyes, Fuyu Zhu, You Li, Xin Wang · 2023 · Journal of Global Health
13. 1918 pandemic influenza virus and Streptococcus pneumoniae co‐infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans
    Kathie‐Anne Walters, Felice D’Agnillo, Zong‐Mei Sheng, Jason Kindrachuk, Louis M. Schwartzman, Rolf E. Kuestner, Daniel S. Chertow, Basil Golding, Jeffery K. Taubenberger, John C. Kash · 2015 · The Journal of Pathology
14. Sialidase‐Based Anti–Influenza Virus Therapy Protects against Secondary Pneumococcal Infection
    Maria Hedlund, Laura M. Aschenbrenner, Kellie A. Jensen, Jeffrey L. Larson, Fang Fang · 2010 · The Journal of Infectious Diseases
15. A Novel Outbred Mouse Model of 2009 Pandemic Influenza and Bacterial Co-Infection Severity
    Kevin J. McHugh, Sivanarayana Mandalapu, Jay K. Kolls, Ted M. Ross, John F. Alcorn · 2013 · PLoS ONE
16. Lethal Synergism between Influenza and Streptococcus pneumoniae
    Jennifer M. Rudd · 2016 · Journal of Infectious Pulmonary Diseases
17. Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System
    Meredith J. Crane, Kayla M. Lee, Ethan S. FitzGerald, Amanda Mercedes Jamieson · 2018 · Frontiers in Immunology
18. Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic
    David Michael Morens, Jeffery K. Taubenberger · 2019 · The Journal of Infectious Diseases
19. Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns
    Jeroen A. Schouten, Jan J. De Waele, Christian Lanckohr, Despoina Koulenti, Nisrine Haddad, Nesrine Rizk, Fredrik Sjövall, Souha Sami Kanj · 2021 · International Journal of Antimicrobial Agents
20. FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals
    Paul M Kelly, Tom C. Kotsimbos, Anna J. Reynolds, Richard R Wood-Baker, Bob Hancox, Simon G.A. Brown, Mark Holmes, Graham Simpson, Simon Bowler, GRANT W. WATERER et al. · 2011 · The Medical Journal of Australia
21. Increased Susceptibility for Superinfection with Streptococcus pneumoniae during Influenza Virus Infection Is Not Caused by TLR7-Mediated Lymphopenia
    Sabine Stegemann‐Koniszewski, Sofia Dahlberg, Andrea Kröger, Marcus Gereke, Dunja Bruder, Birgitta Henriques‐Normark, Matthias Gunzer · 2009 · PLoS ONE
22. Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice
    Yuk-Fai Lau, Lay-Hoon Tang, Eng Eong Ooi, Kanta Subbarao · 2010 · Virology
23. Prevention of influenza by targeting host receptors using engineered proteins.
    Connaris, Helen, Govorkova, Elena A., Ligertwood, Yvonne, Dutia, Bernadette M., Yang, Lei, Tauber, Sandra, Taylor, Margaret A., Alias, Nadiawati, Hagan, Robert, Nash, Anthony A. et al. · 2014 · Proceedings of the National Academy of Sciences
24. Message-passing theory for cooperative epidemics
    Byungjoon Min, Claudio Castellano · 2020 · Chaos An Interdisciplinary Journal of Nonlinear Science
25. A cooperativity between virus and bacteria during respiratory infections
    Chhakchhuak Lalbiaktluangi, Mukesh Yadav, Prashant Kumar Singh, Amit Singh, Mahalaxmi Iyer, Balachandar Vellingiri, Ruth Zomuansangi, Zothanpuia Zothanpuia, Heera Ram · 2023 · Frontiers in Microbiology
26. Adjunctive Corticosteroid Therapy Improves Lung Immunopathology and Survival During Severe Secondary Pneumococcal Pneumonia in Mice
    Hazem E. Ghoneim, J. A. McCullers · 2013 · The Journal of Infectious Diseases
27. Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People
    Elisa Mincholé, Ana L. Figueredo, Manuel Omeñaca, Carolina Panadero, Laura Royo, José Javier Vengoechea, Sergio Fandos, Francisco De Pablo, Salvador Bello · 2016 · PLoS ONE
28. Airway response to respiratory syncytial virus has incidental antibacterial effects
    Charles Sande, James M. Njunge, Joyce Mwongeli Ngoi, Martin N. Mutunga, Timothy K Chege, Elijah Gicheru, Elizabeth Gardiner, Agnes Gwela, Christopher Green, Simon B. Drysdale et al. · 2019 · Nature Communications
29. COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
    Philippe Buchy, Yves Buisson, Otávio Augusto Leite Cintra, Dominic E. Dwyer, Michael D. Nissen, Raúl Ortíz de Lejarazu, Eskild Petersen · 2021 · International Journal of Infectious Diseases
30. The Influenza Pandemic of 2009
    Paul Shapshak, Francesco Chiappelli, Charurut Somboonwit, John T. Sinnott · 2011 · Molecular Diagnosis & Therapy
31. Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship
    Matthew P. Crotty, Shelby Meyers, Nicholas B. Hampton, Stephanie Bledsoe, David J. Ritchie, Richard S. Buller, Gregory A. Storch, Marin H. Kollef, Scott T. Micek · 2015 · Critical Care
32. Time from Illness Onset to Death, 1918 Influenza and Pneumococcal Pneumonia
    Keith P. Klugman, Christina M. Astley, Marc Lipsitch · 2009 · Emerging infectious diseases
33. Age and Location in Severity of COVID‐19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?
    Robert Scott Root-Bernstein · 2020 · BioEssays
34. Super-infection withStaphylococcus aureusinhibits influenza virus-induced type I IFN signalling through impaired STAT1-STAT2 dimerization
    Kathrin Warnking, Carolin Klemm, Bettina Löffler, Silke Niemann, Andre van Krüchten, Georg Peters, Stephan Ludwig, Christina Ehrhardt · 2014 · Cellular Microbiology
35. Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis
    Meng-Huan Wu, Chi-Chun Lin, Shiau-Ling Huang, Hong-Mo Shih, Chung‐Cheng Wang, Chien‐Chang Lee, Jiunn-Yih Wu · 2012 · Influenza and Other Respiratory Viruses
36. STAT1 Is Required for Suppression of Type 17 Immunity during Influenza and Bacterial Superinfection
    Benjamin Lee, Radha Gopal, Michelle L. Manni, Kevin J McHugh, Sivanarayana Mandalapu, Keven Mara Robinson, John F. Alcorn · 2017 · ImmunoHorizons
37. IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and Streptococcus pneumoniae Coinfection
    Shruti Bansal, Vijaya Kumar Yajjala, Christopher D. Bauer, Keer Sun · 2018 · The Journal of Immunology
38. Secondary infections in a cohort of patients with COVID-19 admitted to an intensive care unit: impact of gram-negative bacterial resistance
    Rafael Lessa da Costa, Cristiane da Cruz Lamas, Luiz Fernando Nogueira Simvoulidis, Claudia Adelino Espanha, Lorena Pinto Monteiro Moreira, Renan Alexandre Baptista Bonancim, João Victor Lehmkuhl Azeredo Weber, Max Rogerio Freitas Ramos, Eduardo Costa de Freitas Silva, Liszt Palmeira de Oliveira · 2022 · Revista do Instituto de Medicina Tropical de São Paulo
39. Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death
    Robert Scott Root-Bernstein · 2020 · Vaccines
40. Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective
    P. S. Seethalakshmi, Oliver J. Charity, Theodoros Giakoumis, George Seghal Kiran, Shiranee Sriskandan, Nikolaos Voulvoulis, Joseph Selvin · 2021 · The Science of The Total Environment
41. The Spanish flu
    Patrick Berche · 2022 · La Presse Médicale
42. Family and community concerns about post-mortem needle biopsies in a Muslim society
    E. Gurley, S. Parveen, M. Islam, M. J. Hossain, N. Nahar, N. Homaira, R. Sultana, J. Sejvar, Mahmudur Rahman, S. Luby · 2011 · BMC Medical Ethics
43. Insights on influenza pathogenesis from the grave
    Jeffery K. Taubenberger, John C. Kash · 2011 · Virus Research
44. Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults
    Thomas Alan Bewick, Puja R Myles, Sonia Greenwood, Jonathan S. Nguyen‐Van‐Tam, Stephen James Brett, Malcolm Gracie Semple, Peter Openshaw, Barbara A. Bannister, Robert Charles Read, B L Taylor et al. · 2011 · Thorax
45. Characteristics of hospitalised patients with 2009 H1N1 influenza in Chile
    R. Riquelme, Mauricio Riquelme, María Luisa Rioseco, Carlos Inzunza P., Y. Gomez, C. Contreras, J. Riquelme, Paula Peyrani, Tim L. Wiemken, Julio A. Ramírez · 2010 · European Respiratory Journal
46. Patterns in Bacterial- and Viral-Induced Immunosuppression and Secondary Infections in the ICU
    Rebecca M. Koch, Matthijs Kox, Marien Isaäk de Jonge, Johannes G. van der Hoeven, Gerben Ferwerda, Peter Pickkers · 2016 · Shock
47. The unusually diverse mortality patterns in the Pacific region during the 1918–21 influenza pandemic: reflections at the pandemic's centenary
    G. Dennis Shanks, Nick Wilson, Rebecca J. Kippen, John F. Brundage · 2018 · The Lancet Infectious Diseases
48. Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm
    Isidro García‐Meniño, L. Forcelledo, Yaiza Rosete · 2020 · Journal of Infection and Public Health
49. A Pandemic Lesson for Global Lung Diseases: Exacerbations Are Preventable
    William Cookson, Miriam F. Moffatt, Garth Rapeport, Jennifer Kathleen Quint · 2022 · American Journal of Respiratory and Critical Care Medicine
50. Features of the new pandemic influenza A/H1N1/2009 virus: virology, epidemiology, clinical and public health aspects
    Julian Wei-Tze Tang, Nandini Shetty, Tommy Tsan‐Yuk Lam · 2010 · Current Opinion in Pulmonary Medicine
51. Prevalence of Bacterial Coinfection and Patterns of Antibiotics Prescribing in Patients with COVID-19: A Systematic review and Meta-Analysis
    Faisal Salman Alshaikh, Oula Nawaf Sindi, Brian Godman, Ronald Andrew Seaton, Amanj Baker Kurdi · 2022 · medRxiv
52. Collateral damage of the Covid-19 Pandemic: Exacerbation of Antimicrobial Resistance and Disruptions to Antimicrobial Stewardship Programmes?
    Vindana Chibabhai, Guy Antony Richards, Olga Perovic · 2020 · South African Medical Journal
53. Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome
    Yinfeng Zhang, Cheuk-Yin Lun, Stephen Kwok‐Wing Tsui · 2015 · International Journal of Molecular Sciences
54. Vaccines and global health
    Brian M Greenwood, DAVID M. SALISBURY, Adrian V. S. Hill · 2011 · Philosophical Transactions of the Royal Society B Biological Sciences
55. Effect of the 2009 Influenza A(H1N1) Pandemic on Invasive Pneumococcal Pneumonia
    Katherine E. Fleming-Dutra, Thomas Taylor, Ruth Link‐Gelles, Shikha Garg, Michael A. Jhung, Lyn Finelli, Seema Jain, David K. Shay, Sandra S. Chaves, Joan Baumbach et al. · 2013 · The Journal of Infectious Diseases
56. Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself
    JOHN S. OXFORD, Douglas Gill · 2018 · The Lancet Infectious Diseases
57. Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways
    Vicky Sender, Karina Hentrich, Anuj Kumar Pathak, Alicia Qian Ler Tan, Bethel Tesfai Embaie, Susanna L. Lundström, Massimiliano Gaetani, Jan Bergstrand, Rei Nakamoto, Lok‐To Sham et al. · 2020 · Proceedings of the National Academy of Sciences
58. Infections, inflammation, and risk of neuropsychiatric disorders: the neglected role of “co-infection”
    Amir Abdoli, Ali Taghipour, Majid Pirestani, Mirza Ali Mofazzal Jahromi, Abazar Roustazadeh, Hamed Mir, Hoda Mirzaian Ardakani, Azra Kenarkoohi, Shahab Falahi, Mahdi Karimi · 2020 · Heliyon
59. Opportunistic Infections in COVID-19: A Systematic Review and Meta-Analysis
    Nithin Kurra, Priyanka Isaac Woodard, Nikhila Gandrakota · 2022 · Cureus
60. Assessing the Ecotoxicologic Hazards of a Pandemic Influenza Medical Response
    Andrew C. Singer, Vittoria Colizza A, Heike Schmitt, Johanna E. Andrews, Duygu Balcan, Wei E. Huang, Virginie D. J. Keller, Alessandro Vespignani, Richard J. Williams · 2011 · Environmental Health Perspectives
61. Bacterial–viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospects
    Silvestro Ennio D’Anna, Bruno Balbi, Francesco Cappello, Mauro Carone, Antonino Di Stefano · 2016 · International Journal of COPD
62. The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
    Asmita Ghosh, Anusua Sarkar, Pubali Paul, Parth K. Patel · 2021 · Fungal Biology Reviews
63. IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA
    Qingcong Zheng, Du Wang, Rongjie Lin, Qi Lv, Wanming Wang · 2022 · Frontiers in Immunology
64. Influenza and Pneumonia Mortality in 66 Large Cities in the United States in Years Surrounding the 1918 Pandemic
    Rodolfo Acuña-Soto, Cecile G. Viboud, Gerardo Chowell · 2011 · PLoS ONE
65. Promoting Life Course Vaccination
    Jean‐Pierre Michel, Pierre Olivier Lang · 2011 · Rejuvenation Research
66. Viral–bacterial interactions–therapeutic implications
    Jane C. Deng · 2013 · Influenza and Other Respiratory Viruses
67. Respiratory tract barrier dysfunction in viral-bacterial co-infection cases
    Tomoko Sumitomo, Shigetada Kawabata · 2024 · Japanese Dental Science Review
68. Influenza vaccines: from whole virus preparations to recombinant protein technology
    Victor C. Huber · 2013 · Expert Review of Vaccines
69. Pneumonia Complicating Pandemic (H1N1) 2009
    Diego Viasus, José Ramón Paño‐Pardo, Jerónimo Pachón, Melchor Riera, Francisco López‐Medrano, Antoni Payeras, María Carmen Fariñas, Asunción Moreno, Jesús Rodríguez‐Baño, José Antonio Oteo et al. · 2011 · Medicine
70. Macrophage adaptation in airway inflammatory resolution
    Manminder Kaur, Thomas Bell, Samira Salek‐Ardakani, Tracy Hussell · 2015 · European Respiratory Review
71. HIV and Influenza Virus Infections Are Associated With Increased Blood Pneumococcal Load: A Prospective, Hospital-Based Observational Study in South Africa, 2009-2011
    Nicole Wolter, Cheryl Cohen, Stefano Tempia, Shabir Ahmed Madhi, Marietjie Venter, Jocelyn Moyes, Sibongile Walaza, B. Malope Kgokong, Michelle J. Groome, Mignon du Plessis et al. · 2013 · The Journal of Infectious Diseases
72. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection
    Tomoko Sumitomo, Masanobu Nakata, Satoshi Nagase, Yuki Takahara, Mariko Honda-Ogawa, Yasushi Mori, Yukako Akamatsu, Masaya Yamaguchi, Shigefumi Okamoto, Shigetada Kawabata · 2021 · mBio
73. Variable Legionella Response to Building Occupancy Patterns and Precautionary Flushing
    William J. Rhoads, Meril Sindelar, Céline Margot · 2022 · Microorganisms
74. The Hidden Cost of COVID-19: Focus on Antimicrobial Resistance in Bloodstream Infections
    Giulia Micheli, Flavio Sangiorgi, Francesca Catania, Marta Chiuchiarelli, Federico Frondizi, Eleonora Taddei, Rita Murri · 2023 · Microorganisms
75. Irrational use of antibiotics and factors associated with antibiotic resistance: Findings from a cross‐sectional study in Bangladesh
    Md. Jamal Hossain, Nasrin Jabin, Foyez Ahmmed, Arifa Sultana, S. M. Abdur Rahman, Md. Rabiul Islam · 2023 · Health Science Reports
76. Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations
    Xu, Ji-Qian, Zhang, Wan-Ying, Fu, Jia-Ji, Fang, Xiang-Zhi, Gao, Cheng-Gang, Li, Chang, Yao, Lu, Li, Qi-Lan, Yang, Xiao-Bo, Ren, Le-Hao et al. · 2024 · Military Medical Research
77. Associations Between Viral and Bacterial Potential Pathogens in the Nasopharynx of Children With and Without Respiratory Symptoms
    Chrysanthi L. Skevaki, Paraskevi Tsialta, Aikaterini I. Trochoutsou, Ioanna Logotheti, Heidi Makrinioti, Styliani Τaka, Evangelia Lebessi, Irene Paraskakis, Nikolaos G. Papadopoulos, Maria N Tsolia · 2015 · The Pediatric Infectious Disease Journal
78. Type I Interferons in Bacterial Infections: Taming of Myeloid Cells and Possible Implications for Autoimmunity
    Emily M. Eshleman, Laurel L. Lenz · 2014 · Frontiers in Immunology
79. Pre-infection of pigs with Mycoplasma hyopneumoniae modifies outcomes of infection with European swine influenza virus of H1N1, but not H1N2, subtype
    Céline Deblanc, Stéphane Gorin, Stéphane Quéguiner, Anne V. Gautier‐Bouchardon, Séverine Ferré, Nadia Amenna, Roland Cariolet, Gaëlle Simon · 2011 · Veterinary Microbiology
80. Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection
    Alessandro Boianelli, Niharika Sharma-Chawla, Dunja Bruder, Esteban Abelardo Hernandez-Vargas · 2016 · Frontiers in Cellular and Infection Microbiology
81. The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza
    Amber M. Smith, Victor C. Huber · 2017 · Viral Immunology
82. Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract
    Mirian Domenech, Julio Sempere, Sara de Miguel, José Yuste · 2018 · Frontiers in Immunology
83. Inflammation without Vascular Leakage. Science Fiction No Longer?
    Niall C.J. Filewod, Warren L. Lee · 2019 · American Journal of Respiratory and Critical Care Medicine
84. Meningococcal meningitis and COVID-19 co-infection
    Stuart Declan Gallacher, Andrew Seaton · 2020 · BMJ Case Reports
85. A systematic review on SARS‐CoV‐2‐associated fungal coinfections
    Shringika Soni, Ramesh Namdeo Pudake, Utkarsh Jain, Nidhi Chauhan · 2021 · Journal of Medical Virology
86. Common Childhood Viral Infections
    Sherman J. Alter, Jeffrey S. Bennett, Katylin Koranyi, Andrew J. Kreppel, Ryan Q. Simon · 2015 · Current problems in pediatric and adolescent health care
87. Contribution of innate immune cells to pathogenesis of severe influenza virus infection
    Suzanne Cole, Ling‐Pei Ho · 2017 · Clinical Science
88. A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice
    Erik A. Karlsson, Victoria Meliopoulos, Nicholas C. van de Velde, Lee-Ann Van de Velde, Beth Mann, Geli Gao, Jason W. Rosch, ELAINE I. TUOMANEN, J. A. McCullers, Peter Vogel et al. · 2017 · mBio
89. Conserving genetic resources for agriculture: economic implications of emerging science
    Douglas Gollin · 2020 · Food Security
90. Does virus-bacteria coinfection increase the clinical severity of acute respiratory infection?
    Guilherme Augustto Costa Damasio, Luciane Aparecida Pereira, Suzana Del Rio Moreira, Claudia Nunes Duarte dos Santos, Líbera Maria Dalla-Costa, Sônia Mara Raboni · 2015 · Journal of Medical Virology
91. Temporal Association in Hospitalizations for Tuberculosis, Invasive Pneumococcal Disease and Influenza Virus Illness in South African Children
    Ziyaad Dangor, Alane Izu, David Paul Moore, Marta Coelho Nunes, Fatima Solomon, Natalie Beylis, Anne von Gottberg, Johanna M. McAnerney, Shabir Ahmed Madhi · 2014 · PLoS ONE
92. The Role of Macrophages in Influenza a Virus Infection
    Marlynne Quigg Nicol, Bernadette M. Dutia · 2014 · Future Virology
93. How World War 1 changed global attitudes to war and infectious diseases
    G. Dennis Shanks · 2014 · The Lancet
94. Mutually cooperative epidemics on power-law networks
    Peng-Bi Cui, Francesca Colaiori, Claudio Castellano · 2017 · Physical review. E
95. Port d’Entrée for Respiratory Infections – Does the Influenza A Virus Pave the Way for Bacteria?
    Nikolai Siemens, Sonja Oehmcke-Hecht, Thomas C. Mettenleiter, Bernd Kreikemeyer, Peter Valentin‐Weigand, Sven Hammerschmidt · 2017 · Frontiers in Microbiology
96. Enhanced IL-1β production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae
    Angeline E. Rodriguez, Christopher Bogart, Christopher M. Gilbert, Jonathan A. McCullers, Amber M. Smith, Thirumala‐Devi Kanneganti, Christopher R. Lupfer · 2019 · PLoS ONE
97. Induction of cyclophilin A by influenza A virus infection facilitates group A Streptococcus coinfection
    Xiaoyuan Bai, Wenxian Yang, Xiaohan Luan, Huizi Li, Heqiao Li, Deyu Tian, Wenhui Fan, Jing Li, Beinan Wang, Wenjun Liu et al. · 2021 · Cell Reports
98. Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study
    Manish Kumar Pandey, Alexander May, Laura Tan, Harriet C. Hughes, Jack Parry Jones, Wendy Harrison, Scott Bradburn, Sam Tyrrel, Babu Muthuswamy, Nidhika Berry et al. · 2022 · Critical Care
99. Influenza A(H1N1)pdm09 and Cystic Fibrosis Lung Disease: A Systematic Meta-Analysis
    Hanna Renk, Nicolas Regamey, Dominik Hartl · 2014 · PLoS ONE
100. Bacterial Pneumonia in Older Adults
     Thomas James Marrie, Thomas M. File · 2016 · Clinics in Geriatric Medicine